Why Attend the CluePoints and HighPoint Solutions Roadshow?
During the events, we will review what’s needed from a people, process and technology standpoint to adopt a risk-based approach to study execution, featuring:
- The key updates to the ICH E6 GCP.
- How to drive ICH E6 (R2) compliance.
- Why RBM is necessary for clinical studies and the benefits that can be derived from a centralized approach to monitoring.
- The value in aggregating study data to make better decisions (e.g. Quality Tolerance Limits), based on industry metrics.
- Best practice for study planning and execution, including pre-study risk assessment.
- How to assess the effectiveness of your clinical technology and processes.
- How to manage the change in your organization.
- The technology available to underpin your RBM strategy.
- Case studies that illustrate the benefits of using an automated statistical approach.
- Our vision of RBM for the next 5 years.